151 related articles for article (PubMed ID: 5253463)
1. Platelet survival studies in man. With special reference to thrombosis and atherosclerosis.
Abrahamsen AF
Scand J Haematol Suppl; 1968; 3():1-53. PubMed ID: 5253463
[No Abstract] [Full Text] [Related]
2. beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction.
Zahavi J; Kakkar VV
Thromb Haemost; 1980 Aug; 44(1):23-9. PubMed ID: 6158764
[No Abstract] [Full Text] [Related]
3. Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.
O'Brien JR; Etherington MD; Jamieson S; Lawford P; Lincoln SV; Alkjaersig NJ
Thromb Diath Haemorrh; 1975 Nov; 34(2):483-97. PubMed ID: 53892
[TBL] [Abstract][Full Text] [Related]
4. [Determination of platelet survival time and anticipation of thrombus formation].
Tsukada T
Nihon Rinsho; 1978 Dec; 36(12):3842-7. PubMed ID: 372623
[No Abstract] [Full Text] [Related]
5. The role of ABO blood groups in dynamic coagulation and thrombus formation in vascular disease. An in vitro study.
Dintenfass L
Haematologia (Budap); 1971; 5(3):205-16. PubMed ID: 5128745
[No Abstract] [Full Text] [Related]
6. [Clinical and experimental studies on thrombocyte aggregation in vascular diseases].
Breddin K
Dtsch Med Wochenschr; 1968 Aug; 93(33):1555-6 passim. PubMed ID: 5662603
[No Abstract] [Full Text] [Related]
7. [Studies on the adhesive capacity of thrombocytes in patients with afflictions of the circulatory system (author's transl)].
Köstering H; Walther C; Grüne M; König F; Völker P
Z Klin Chem Klin Biochem; 1973 May; 11(5):215-9. PubMed ID: 4804175
[No Abstract] [Full Text] [Related]
8. [STA (serum thrombotic accelerator) activity, with special reference to changes in the STA activity in the serum from patients with hypercoagulable state. 2. Clinical studies].
Nakamura Y
Nihon Ketsueki Gakkai Zasshi; 1970 Apr; 33(2):256-72. PubMed ID: 5530049
[No Abstract] [Full Text] [Related]
9. Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.
Harker LA; Slichter SJ
Thromb Diath Haemorrh; 1974 May; 31(2):188-203. PubMed ID: 4850635
[No Abstract] [Full Text] [Related]
10. [The measurement of thrombocyte adhesiveness. First experiences with a new method].
Baumgartner HR; Cronquist M; Wobmann P; Streuli F; Duckert F
Schweiz Med Wochenschr; 1967 Dec; 97(50):1674-9. PubMed ID: 5302273
[No Abstract] [Full Text] [Related]
11. Platelet survival and adhesiveness in recurrent venous thrombosis.
Steele PP; Weily HS; Genton E
N Engl J Med; 1973 May; 288(22):1148-52. PubMed ID: 4699744
[No Abstract] [Full Text] [Related]
12. Platelet function long after arterial and venous thrombosis.
O'Brien JR; Etherington M; Jamieson S; Klaber MR; Lincoln SV
Thromb Diath Haemorrh; 1974 May; 31(2):279-90. PubMed ID: 4853678
[No Abstract] [Full Text] [Related]
13. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
[TBL] [Abstract][Full Text] [Related]
14. [Determination of human sensitivity to the antiaggregation action of acetylsalicylic acid].
Baluda VP; Lukoianova TI; Deianov I
Lab Delo; 1986; (4):221-3. PubMed ID: 2423755
[No Abstract] [Full Text] [Related]
15. [The role of thrombocytes in the etiopathogenesis of various vascular disorders].
Hopp L
Orv Hetil; 1981 Dec; 122(50):3065-70. PubMed ID: 7329682
[No Abstract] [Full Text] [Related]
16. Blood viscosity and thrombosis: clinical considerations.
Smith BD; La Celle PL
Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
[TBL] [Abstract][Full Text] [Related]
17. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
Fischer M
Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
[No Abstract] [Full Text] [Related]
19. The behaviour of lipoprotein(a) in patients with various diseases.
Van Wersch JW
Scand J Clin Lab Invest; 1994 Nov; 54(7):559-62. PubMed ID: 7863233
[TBL] [Abstract][Full Text] [Related]
20. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
